Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?

Jarjour M, Ducharme A

Open source

DOI
10.7573/dic.2023-5-6
Published
2023
Container
Drugs in context
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7573/dic.2023-5-6,
  title = {Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?},
  author = {Jarjour M and Ducharme A},
  year = {2023},
  journal = {Drugs in context},
  doi = {10.7573/dic.2023-5-6},
  url = {https://doi.org/10.7573/dic.2023-5-6}
}

RIS

TY  - JOUR
TI  - Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?
AU  - Jarjour M
AU  - Ducharme A
PY  - 2023
JO  - Drugs in context
DO  - 10.7573/dic.2023-5-6
UR  - https://doi.org/10.7573/dic.2023-5-6
ER  - 

APA

M, J., & A, D. (2023). Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?. Drugs in context. https://doi.org/10.7573/dic.2023-5-6

Source records